Nimetazepam-D3

Description

 RESTRICTED PRODUCT 

Schedule 4 (S4) Licence required.

This product requires an Australian government issued permit to hold or possess.

A stable-labled internal standard suitable for quantitation of Nimetazepamlevels in urine, serum, or plasma by LC/MS or GC/MS for forensic analysis,clinical toxicology, or urine drug testing. Nimetazepam, marketed as thebenzodiazepine drug Erimin, is prescribed for the treatment of stress orshort-term severe insomnia in patients who have difficulty falling asleep ormaintaining sleep. Although not used therapeutically in the US, the drug is knownfor its use to soften the comedown after use of methamphetamine or otherstimulants.